Skip to main content

Primary Cervical Dystonia

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Neuronetics
NeuroneticsMALVERN, PA
1 program
NeuroStar TMS therapyN/A1 trial
Active Trials
NCT02542839Completed9Est. Jun 2021
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
transcranial electrical stimulationN/A1 trial
Active Trials
NCT03369613Completed36Est. Sep 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Colorado Therapeuticstranscranial electrical stimulation
NeuroneticsNeuroStar TMS therapy

Clinical Trials (2)

Total enrollment: 45 patients across 2 trials

NCT03369613Colorado Therapeuticstranscranial electrical stimulation

Transcranial Electrical Stimulation for Cervical Dystonia

Start: Oct 2017Est. completion: Sep 202136 patients
N/ACompleted
NCT02542839NeuroneticsNeuroStar TMS therapy

rTMS and Botulinum Toxin in Primary Cervical Dystonia

Start: Nov 2015Est. completion: Jun 20219 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.